In an event that once again underscores their dedication to social responsibility, Sanofi, a prominent figure in global healthcare, has clinched the “Corporate Social Impact Award 2024 – Gold level” from the American Chamber of Commerce in Thailand (AmCham Thailand) for the fifth consecutive year. This accolade is a testament to Sanofi’s unwavering commitment to practices that emphasize both community growth and social responsibility. The company proudly stands at the forefront of initiatives that bolster the quality of life in Thai society while championing sustainability. At the recent gala held at the Avani+ Riverside Bangkok Hotel, Ms. Mantana Tanprasert, Head of Vaccines for Thailand and Myanmar, and Mr. Charles Trolliet, Head of Commercial Thailand, Pharma Business, were on hand to gracefully receive the award.
From its very foundation, Sanofi Thailand has been an innovator in the realm of healthcare, tirelessly working to both prevent and address medical issues that impact the populace. The strategic interplay between cutting-edge scientific research, efficient manufacturing, data, and digital prowess propels Sanofi to transform scientific innovation into tangible healthcare solutions. Their service range is vast, encompassing vaccine-driven disease prevention to treatments that alleviate pain and enhance life quality. Special emphasis is placed on patients with rare ailments as well as the multitude tackling chronic diseases.
Mr. Eric Mansion, the General Manager of Pharma Business for South-East Asia & India (SEA&I) and Multi-Country Organization (MCO) Lead, expressed, “As a global leader in healthcare innovation spanning over 70 nations, Sanofi is resolutely bound by our mission: ‘We Chase the Miracles of Science to Improve People’s Lives.’ Our relentless commitment to research and development allows us to provide unparalleled solutions, driven by advanced technologies and a patient-focused methodology. Operating in the SEA&I region, which is home to a burgeoning population of over 2 billion, we recognize the vital components of healthcare access, environmental stewardship, and social impact. Sanofi is devoted to raising disease awareness for self-management and promoting ecological consciousness, all intertwined within our overarching aim to enhance lives.”
Mr. Charles Trolliet, who is at the helm of social impact initiatives in Thailand, shared insights into Sanofi’s efforts: “Sanofi Thailand is dedicated to offering equitable and sustainable access to innovative treatments for Thai patients. Two groundbreaking projects were unveiled this year:
- Sanofi Planet Care Upcycling Programme: Responding to the urgencies posed by global warming and severe climate shifts, we’ve allied with six major hospitals to motivate diabetes patients to return used insulin pens. This initiative curtails plastic waste through repurposing, showing considerable success and heralding our plans for expansion next year.
- Kids & Diabetes in Schools (KiDS): Engaged by a worldwide campaign from Sanofi and the International Diabetes Federation (IDF), this initiative was rolled out in Thailand last June, focusing on diabetes education for children and adolescents through emphasizing an active lifestyle, nutritious diets, and sufficient sleep. Partnering with the Diabetes Association of Thailand and the Medical Service Department of the Bangkok Metropolitan Administration (BMA), we offered ‘Train the Trainers’ workshops. Sanofi volunteers took the KiDS program into a Bangkok secondary school, with a special event aligned with World Diabetes Day.”
Ms. Mantana Tanprasert reiterated, “This award fuels our passion for advancing scientific breakthroughs that elevate Thai societal health. Our pursuits yield significant impacts—spanning the gamut from transformational treatments and boosting health literacy, to advocating for lifelong immunization, particularly among vulnerable segments like infants, children, and the elderly. We renew our pledge to foster the health and vitality of Thai communities.”
The recognition from the AmCham Corporate Social Impact Award 2024 not only celebrates Sanofi’s core mission—”We Chase the Miracles of Science to Improve People’s Lives”—but also reflects their extensive commitment to pushing the boundaries of healthcare, leveling the health equity playing field, and nurturing our planet, all aimed at leaving a persistent, positive imprint on the communities they cherish and support.
While it’s great that Sanofi is being recognized for their social impact, I can’t help but wonder how much of this is just corporate PR.
Everything companies do is PR, but if they’re genuinely helping communities, does it matter?
Maybe, but I’d like to see more transparency on how they balance profit and social impact.
Agreed, Anna. They should publish detailed reports on their initiatives, not just awards.
Sanofi seems to be genuinely concerned with healthcare access and environmental issues. Their efforts in Thailand are commendable.
The upcycling program is a step in the right direction, but what about the carbon footprint of their manufacturing?
Good point, EcoWarrior. Reducing plastic waste is important, but comprehensive sustainability needs to address all areas.
Their focus on diabetes education for kids is commendable. Preventative education can save so many lives.
Education is key. It’s nice to see big companies taking responsibility.
True, but we also need to address the root causes of rising diabetes rates.
I am skeptical about big corporations like Sanofi and their motives. They always have an angle.
Even if they do have an angle, if it results in positive outcomes, isn’t that a win?
Possibly, but we should always remain cautious and critical about why they’re doing it.
People forget the ethical responsibility corporations have when they’re driven by profit. There are no altruistic megacorporations.
The KiDS initiative sounds great, but how effective is it really? We need data on its impact.
Measuring social impact is difficult, but even small changes can make huge differences in community health.
But without concrete data, how do we know what’s working and what isn’t?
5 years of being awarded is impressive. Clearly, they must be doing something right.
Or perhaps they’re just really good at writing award applications.
Would love to see Sanofi’s programs expand to rural communities where the need is even greater.
Sounds awesome, but I’ve heard nothing about this in rural Thailand where I stay. What’s the coverage area actually like?
That’s a good point. Outreach might be limited to urban or semi-urban areas. It’d be great to hear directly from those affected.
The focus on sustainability is what stands out. More corporations need to take similar initiatives.
It’s all well and good, but are local Thai companies getting overshadowed by such international giants?
Awards are nice, but real change can’t be awarded, it’s experienced every day by those impacted.
How are they using tech and data in these programs? That’s where the real innovation lies.
At least one big player is taking an interest in social issues. Better than the complete absence we see elsewhere.
Even if this is just a marketing strategy, the companies’ impact on health issues remains positive.
I hope they keep up the good work and expand to benefit underserved regions.
Ultimately, there are always pros and cons. The key is ensuring ethical approaches are consistent and genuine.
This will only make a difference in the long run if not done half-heartedly.
Let’s see if they keep winning in the upcoming years. Consistency would definitely be a strong indicator of their impact.